Aura Biosciences Statistics
Total Valuation
AURA has a market cap or net worth of $399.44 million. The enterprise value is $247.07 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AURA has 63.50 million shares outstanding. The number of shares has increased by 15.97% in one year.
| Current Share Class | 63.50M |
| Shares Outstanding | 63.50M |
| Shares Change (YoY) | +15.97% |
| Shares Change (QoQ) | +13.65% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 43.45% |
| Float | 36.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.11.
| Current Ratio | 9.04 |
| Quick Ratio | 8.60 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.26% and return on invested capital (ROIC) is -38.49%.
| Return on Equity (ROE) | -64.26% |
| Return on Assets (ROA) | -35.84% |
| Return on Invested Capital (ROIC) | -38.49% |
| Return on Capital Employed (ROCE) | -66.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$976,752 |
| Employee Count | 109 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AURA has paid $117,000 in taxes.
| Income Tax | 117,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.18% in the last 52 weeks. The beta is 0.44, so AURA's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -31.18% |
| 50-Day Moving Average | 5.91 |
| 200-Day Moving Average | 6.28 |
| Relative Strength Index (RSI) | 58.46 |
| Average Volume (20 Days) | 211,420 |
Short Selling Information
The latest short interest is 2.92 million, so 4.60% of the outstanding shares have been sold short.
| Short Interest | 2.92M |
| Short Previous Month | 2.92M |
| Short % of Shares Out | 4.60% |
| Short % of Float | 7.98% |
| Short Ratio (days to cover) | 10.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -113.36M |
| Pretax Income | -106.35M |
| Net Income | -106.47M |
| EBITDA | -112.21M |
| EBIT | -113.36M |
| Earnings Per Share (EPS) | -$1.90 |
Full Income Statement Balance Sheet
The company has $161.87 million in cash and $17.75 million in debt, giving a net cash position of $144.11 million or $2.27 per share.
| Cash & Cash Equivalents | 161.87M |
| Total Debt | 17.75M |
| Net Cash | 144.11M |
| Net Cash Per Share | $2.27 |
| Equity (Book Value) | 156.67M |
| Book Value Per Share | 2.49 |
| Working Capital | 151.30M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$88.23 million and capital expenditures -$570,000, giving a free cash flow of -$88.80 million.
| Operating Cash Flow | -88.23M |
| Capital Expenditures | -570,000 |
| Free Cash Flow | -88.80M |
| FCF Per Share | -$1.40 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.97% |
| Shareholder Yield | -15.97% |
| Earnings Yield | -27.22% |
| FCF Yield | -22.70% |
Analyst Forecast
The average price target for AURA is $20.33, which is 223.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.33 |
| Price Target Difference | 223.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |